A pilot study of garlic consumption shows no significant effect on markers of oxidation or sub-fraction composition of low-density lipoprotein including lipoprotein(a) after allowance for non-compliance and the placebo effect

Clinica Chimica Acta

Volumn 285, Issue 1-2, 1999, Pages 21-33

  Byrne, D J ^a   Neil, H A W ^b   Vallance, D T ^a,c   Winder, A F ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

Allium sativum; Antioxidants; Garlic; Lipoprotein(a); Low density lipoprotein

Indexed keywords

ANTIOXIDANT; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GARLIC; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID OXIDATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OXIDATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; GARLIC; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PATIENT COMPLIANCE; PILOT PROJECTS; PLACEBO EFFECT; PLANTS, MEDICINAL;

EID: 0032770063     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00063-7     Document Type: Article

References (30)

1. Mansell P, Reckless JPD. Garlic. Effects on serum lipids, blood pressure, coagulation, platelet aggregation, and vasodilatation. Br Med J 1991;303:379-80.
2. Phelps S, Harris WS. Garlic supplementation and lipoprotein oxidation susceptability. Lipids 1993;28:475-7.
3. Neil HAW, Silagy CA, Lancaster T, Hodgeman J, Vos K, Moore JW, Jones L, Cahill J, Fowler GH. Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J R Coll Phys Lond 1996;30:329-34.
4. Silagy C, Neil A. Garlic as a lipid lowering agent - a meta-analysis. J R Coll Phys Lond 1994;28:39-45.
5. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
6. Popov I, Blumstein A, Lewin G. Antioxidant effects of aqueous garlic extract. 1st communication: direct detection using the photoluminescence. Arzneim Forsch/Drug Res 1994;44:602-7.
7. Efendy JL, Simmons DL, Campbell GR, Campbell JH. The effect of the aged garlic extract, 'Kyolic', on the development of experimental atherosclerosis. Atherosclerosis 1997;132:37-42.
8. Esterbauer H, Striegl G, Puhl H, Rothender M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
9. Kleinveld HA, Hak-Lemmers HLM, Stalenhoef AFH, Demacker PNM. Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem 1992;38:2066-72.
10. Editorial. Antibodies to oxidised LDL in atherosclerosis. Lancet 1992;339:899-900.
11. Bergmark C, Wu R, deFaire U, Lefvert AK, Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidised LDL. Arterioscler Thromb Vasc Biol 1995;15:441-5.
12. Bui MN, Sack MN, Moutsatos G, Lu DY, Katz P, McCown R, Breall JA, Rackley CE. Autoantibody titres to oxidised low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J 1996;131:663-7.
13. Aviram M, Lund-Katz S, Phillips MC, Chait A. The influence of the triglyceride content of low-density lipoprotein on the interaction of apolipoprotein B-100 with cells. J Biol Chem 1988;263:16842-8.
14. DeGraaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arteriosclerosis 1991;11:298-306.
15. Dejager S, Bruckert E, Chapman MJ. Dense LDL sub-species with diminished oxidative resistance predominate in combined hyperlipidaemia. J Lipid Res 1993;34:295-308.
16. Beaudeux L J-, Gardes-Albert M, Delattre J, Legrand A, Rousselet F, Peynet J. Resistance of lipoprotein(a) to lipid peroxidation induced by oxygenated free radicals produced by y radiolysis: a comparison with low-density lipoprotein. Biochem J 1996;314:277-84.
17. Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ. Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. J Lipid Res 1992;33:1551-61.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma without use of the ultracentrifuge. Clin Chem 1972;18:499-502.
19. Rice-Evans CA, Diplock AT, Symons MCR. Techniques in free radical research. In: Burdon RH, van Knippenberg PH, editors, Laboratory techniques in biochemistry and molecular biology, Amsterdam: Elsevier, 1991, pp. 185-97, ch. 6.
20. McDowell IFW, McEnemy J, Trimble ER. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann Clin Biochem 1995;32:167-74.
21. Muniz N. Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel. Clin Chem 1977;23:1826-33.
22. Rajman I, Kendall MJ, Cramb R, Holder RL, Salih M, Gamage MD. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 1996;125:231-42.
23. Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary disease. Clin Chem 1988;34:B78-83.
24. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient centrifugation. Atherosclerosis 1990;83:59-67.
25. Simons LA, Balasubramaniam S, vonKoningsmark M, Parfitt A, Simons J, Peters W. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis 1995;113:219-25.
26. Gøtzsche PC. Is there a logic in the placebo? Lancet 1994;344:925-6.
27. Maes M, Weeckx S, Wauters A, Neels H, Scharpe S, Verkerk R, Demedts P, Desnyder R. Biological variability in serum vitamin E concentrations: relation to serum lipids. Clin Chem 1996;42:1824-31.
28. Winklhofer-Roob BM, van'tHof MA, Shmerling D. Reference values for plasma concentrations of vitamin E and A and carotenoids in a Swiss population from infancy to adulthood, adjusted for seasonal influences. Clin Chem 1997;43:146-53.
29. Reaven P, Parathasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL. Effects of oleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification. J Clin Invest 1993;91:668-76.
30. Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic preparation on serum lipoproteins and cholesterol metabolism. J Am Med Assoc 1998;279:1900-2.